663 filings
Page 13 of 34
8-K
LPCN
Lipocine Inc
11 May 20
Other Events
8:01am
8-K
LPCN
Lipocine Inc
7 May 20
First Quarter and Recent Corporate Highlights
8:02am
10-Q
2020 Q1
LPCN
Lipocine Inc
Quarterly report
7 May 20
8:01am
8-K
LPCN
Lipocine Inc
5 May 20
Other Events
8:35am
DEF 14A
LPCN
Lipocine Inc
Definitive proxy
28 Apr 20
8:01am
8-K
LPCN
Lipocine Inc
21 Apr 20
Other Events
8:00am
8-K
LPCN
Lipocine Inc
17 Apr 20
Other Events
8:00am
424B5
LPCN
Lipocine Inc
10 Apr 20
Prospectus supplement for primary offering
4:01pm
8-K
LPCN
Lipocine Inc
9 Apr 20
Lipocine Announces US Court of Appeals for the Federal Circuit Affirms Decision of USPTO
8:01am
8-K
LPCN
Lipocine Inc
1 Apr 20
Impact of A New Oral Testosterone Undecanoate on Blood Pressure and Cardiovascular Risk
8:01am
8-K
LPCN
Lipocine Inc
26 Mar 20
Lipocine Announces Outcome of Markman Hearing in Patent Infringement Suit Against Clarus
8:00am
4
LPCN
Lipocine Inc
18 Mar 20
Lipocine / John W. Higuchi ownership change
11:20am
8-K
LPCN
Lipocine Inc
13 Mar 20
Lipocine Announces 2019 Year End Financial and Operational Results
8:03am
10-K
2019 FY
LPCN
Lipocine Inc
Annual report
13 Mar 20
8:01am
8-K
LPCN
Lipocine Inc
4 Mar 20
Other Events
8:00am
8-K
LPCN
Lipocine Inc
27 Feb 20
Lipocine Announces Closing of Registered Direct Offering of Common Stock and Warrants
4:19pm
424B5
LPCN
Lipocine Inc
26 Feb 20
Prospectus supplement for primary offering
8:02am
8-K
LPCN
Lipocine Inc
26 Feb 20
Entry into a Material Definitive Agreement
8:01am
SC 13G
LPCN
Lipocine Inc
25 Feb 20
Beneficial ownership report
12:39pm
8-K
LPCN
Lipocine Inc
25 Feb 20
Lipocine Announces $6 Million Registered Direct Offering Priced At-the-market
8:38am